Debra Evans
Adult Health · Farrell, PANPI 1609833581
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by AstraZeneca at 38.3% of the total. Reporting peaked in 2022 at $24,441 and has fallen 62.7% since, to $9,112 in 2025. Among adult health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $450.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$32K
- E.r. Squibb & Sons, L.L.C.$30K
- Mirati Therapeutics, Inc.$12K
- Bristol Myers Squibb$7K
- Catalyst Pharmaceuticals, Inc.$1K
- G1 Therapeutics, Inc.$1K
- plus $724 from 7 others
What the payments were for
- Consulting fees$22,67527%
- Speaking & faculty fees$49,03658%
- Travel & lodging$8,41810%
- Food & beverage$4,3445%
- Education$1670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 70 | $32,402 |
| E.r. Squibb & Sons, L.L.C. | 67 | $29,958 |
| Mirati Therapeutics, Inc. | 24 | $12,127 |
| Bristol Myers Squibb | 9 | $6,645 |
| Catalyst Pharmaceuticals, Inc. | 3 | $1,461 |
| G1 Therapeutics, Inc. | 3 | $1,324 |
| Eisai Inc. | 4 | $282 |
| Amgen | 1 | $125 |
| Incyte Corporation | 1 | $100 |
| Jazz Pharmaceuticals Inc. | 2 | $80 |
| Sanofi | 1 | $75 |
| Novartis | 2 | $49 |
| Seagen Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$84,641 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 16 | $45,879 |
| Anastrozole | 88 | $1,698 |
| Oxycodone Hcl | 35 | $984 |
| Potassium Chloride | 34 | $376 |
| Hydroxyurea | 28 | $319 |
| Prochlorperazine Maleate | 11 | $163 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 11 | $144 |
| Acyclovir | 15 | $108 |
| Prednisone | 21 | $68 |
| Levothyroxine Sodium | 25 | $35 |
Paid to pharmacies, not to this prescriber.
Other adult health in Farrell
- Beth SandyPhiladelphia$924K
- Jennifer MondilloSchwenksville$396K
- Diane NewmanPhiladelphia$343K
- Elizabeth FaustDouglassville$342K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Jennifer KeeleyWexford$97K
- Bethann MallonBlue Bell$65K
- Catherine HoldsworthPhiladelphia$64K
- Melissa LaporteWilkes Barre$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.